Review: Addition of inhaled corticosteroids to long-acting β2-agonists does not improve outcomes in stable COPD

被引：0
|
作者：
Aaron, Shawn D. [1 ]
机构：
[1] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
来源：
ANNALS OF INTERNAL MEDICINE | 2010年 / 152卷 / 06期
关键词：
D O I：
10.7326/0003-4819-152-6-201003160-02005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Benefits of long-acting β2-agonists
    Lipworth, Brian J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (03) : 725 - 725
  • [42] Pharmacogenomics of long-acting β2-agonists
    Blake, Kathryn
    Lima, John
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (11) : 1733 - 1751
  • [43] Increased doses of inhaled corticosteroids versus addition of long-acting β2 agonists for treatment of asthma
    Choi, J.
    Oh, M.
    Lee, B.
    Choi, D.
    Jeung, Y.
    ALLERGY, 2010, 65 : 553 - 554
  • [44] Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children
    Chauhan, Bhupendrasinh F.
    Chartrand, Caroline
    Chroinin, Muireann Ni
    Milan, Stephen J.
    Ducharme, Francine M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (11):
  • [45] New long-acting β2-agonists
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (09) : 1385 - 1388
  • [46] Effects of Inhaled Corticosteroids, Leukotriene Receptor Antagonists, or Both, Plus Long-Acting β2-Agonists on Asthma Pathophysiology: a Review of the Evidence
    A. Maurizio Vignola
    Drugs, 2003, 63 (Suppl 2) : 35 - 51
  • [47] Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history
    Bateman, E. D.
    Rabe, K. F.
    Calverley, P. M. A.
    Goehring, U. M.
    Brose, M.
    Bredenbroeker, D.
    Fabbri, L. M.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (03) : 553 - 560
  • [48] Safety of long-acting β-agonists in stable COPD -: A systematic review
    Rodrigo, Gustavo J.
    Nannini, Luis J.
    Rodriguez-Roisin, Roberto
    CHEST, 2008, 133 (05) : 1079 - 1087
  • [49] Should combination therapy with inhaled corticosteroids and long-acting β2-agonists be prescribed as initial maintenance treatment for asthma?
    Lemière, C
    Becker, A
    Boulet, LP
    Bowie, D
    Cartier, A
    Cockroft, D
    Cowie, R
    Ernst, P
    Fitzgerald, M
    Sears, M
    Spier, S
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 167 (09) : 1008 - 1009
  • [50] Inhaled corticosteroids and long-acting β2-agonists in treatment of patients with chronic bronchiolitis following exposure to sulfur mustard
    Ghanei, Mostafa
    Shohrati, Majid
    Harandi, Ali Amini
    Eshraghi, Mehdi
    Aslani, Jafar
    Alaeddini, Farshid
    Manzoori, Hasan
    INHALATION TOXICOLOGY, 2007, 19 (10) : 889 - 894
12345